ARTICLE | Company News
Nuvilex cancer, endocrine/metabolic news
September 2, 2013 7:00 AM UTC
Nuvilex restructured and formed three new divisions to focus on its biotechnology core businesses after completing its acquisition of Bio Blue Bird AG from SG Austria Pvt. Ltd. (Singapore). Through it...